Biocryst Pharmaceuticals buy TD Cowen
Start price
15.10.25
/
50%
€5.62
Target price
15.10.26
€25.82
Performance (%)
14.80%
Price
12.12.25
€6.45
Summary
This prediction is currently active. The prediction currently has a performance of 14.80%. This prediction currently runs until 15.10.26. The prediction end date can be changed by TD_Cowen at any time. TD_Cowen has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biocryst Pharmaceuticals | -1.073% | -1.073% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by TD_Cowen for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals (NASDAQ:BCRX) is now covered by analysts at TD Cowen. They set a "buy" rating and a $30.00 price target on the stock.
Ratings data for BCRX provided by MarketBeat